Induction therapy confers survival advantage in mechanically supported patients regardless of peak CPRA in heart transplantation
Patients requiring MCS prior to heart transplantation have significantly improved post-transplant survival with induction therapy, regardless of their peak CPRA. TCDA confers decreased number of acute rejection episodes at 1 year in this patient population.
Authors
- Maria Currie (ORCID: https://orcid.org/0000-0002-5822-837X)
- Nataliya Bahatyrevich (ORCID: https://orcid.org/0000-0003-0882-7363)
- Katharine Casselman Pines (ORCID: https://orcid.org/0000-0003-4073-954X)
- Reid Dale (ORCID: https://orcid.org/0000-0003-0072-3375)
- Matthew Leipzig
- Shirin Jimenez
Institutions
- University of California, Davis (US)
- Stanford University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100246
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- International Society for Heart and Lung Transplants
- NHLBI Division of Intramural Research